Clinical trial
The Development and Feasibility Testing of an Intervention Programme to Reduce Cognitive Impairment Due to Cancer Treatment
NCT02581709 is registered in ClinicalTrials.gov with Queen's University, Belfast as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Development and Feasibility Testing of an Intervention Programme to Reduce Cognitive Impairment Due to Cancer Treatment
- Lead sponsor
- Queen's University, Belfast
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 31, 2016
- Completion date
- October 31, 2017
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.